Protalex Inc

(PRTX)

By |

Profile

Protalex Inc is a United States-based clinical stage company. It is primarily focused on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and immune thrombocytopenia. The key product candidate of the group is PRTX-100, an immunomodulatory therapy, which is a bacterial protein known to modify aspects of the human immune system. PRTX-100 is effective in animal models of autoimmune diseases and has demonstrated activity on cultured human immune cells at very low concentrations.

Contact Information

Website: www.protalex.net
Email: investorrelations@protalex.com
Main Phone: +1 215 862-9720
Address: 131 Columbia Turnpike
Address 2: Suite 1
State: NJ
City / Town: Florham Park
Country: USA
Postal Code: 07932

Issuer Information

Exchange: OTCQB
CEO: Arnold P. Kling
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.10 $ -0.03 (-23.08%)
Last Price 0.10 Change $ -0.03 Change % -23.08 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.15 High 0.15 Low 0.065 Prev Close 0.13
Last Trade Volume 39,617 52 Wk Hi 1.20 52 Wk Low 0.13
Market Cap 4.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 47,325,387.00 EPS (TTM) -0.17 PE Ratio N/A Exchange OTCQB
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 10 10 10 10
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/02/16 05/02/16 05/02/16 05/02/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1